Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

SP Kim; CP Gross; QD Trinh; MC Smaldone; RH Thompson; SP Psutka; H Van Houten; LC Han; R Abouassaly; JD Sammon; M Sun; ND Shah

Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

SP Kim
, CP Gross
, QD Trinh
, MC Smaldone
, RH Thompson
, SP Psutka
, H Van Houten
, LC Han
, R Abouassaly
, JD Sammon
, M Sun
, ND Shah

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	E141-E146
Number of pages	6
Journal	American Journal of Pharmacy Benefits
Volume	7
Issue number	6
State	Published - 2015

Cite this

@article{18c1324a0b3b45ca8fddec05afaffd16,

title = "Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma",

author = "SP Kim and CP Gross and QD Trinh and MC Smaldone and RH Thompson and SP Psutka and \{Van Houten\}, H and LC Han and R Abouassaly and JD Sammon and M Sun and ND Shah",

year = "2015",

language = "American English",

volume = "7",

pages = "E141--E146",

journal = "American Journal of Pharmacy Benefits",

issn = "1945-4481",

publisher = "Managed Care and Healthcare Communications",

number = "6",

}

TY - JOUR

T1 - Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

AU - Kim, SP

AU - Gross, CP

AU - Trinh, QD

AU - Smaldone, MC

AU - Thompson, RH

AU - Psutka, SP

AU - Van Houten, H

AU - Han, LC

AU - Abouassaly, R

AU - Sammon, JD

AU - Sun, M

AU - Shah, ND

PY - 2015

Y1 - 2015

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000410458500001&DestLinkType=FullRecord&DestApp=WOS

M3 - Article

SN - 1945-4481

VL - 7

SP - E141-E146

JO - American Journal of Pharmacy Benefits

JF - American Journal of Pharmacy Benefits

IS - 6

ER -

Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

Other files and links

Fingerprint

Cite this